Brilliant Violet 711™ anti-human CD4 344648 from BioLegend

Product Specs
ItemBrilliant Violet 711™ anti-human CD4
CompanyBioLegend
Price $406.00Supplier Page View Company Product Page
Catalog Number344648
Quantity100 tests
ApplicationsFC - Quality tested
Conjugate/TagBrilliant Violet 711™
FormatPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
ReactivityHuman
TargetCD4
IsotypeMouse IgG1, kappa
CloneSK3
HostMouse
Antibody TypePrimary
NCBI Full Gene NameCD4 molecule
NCBI Gene AliasesCD4mut, IMD79, Leu-3, OKT4D, T4
ClonalityMonoclonal
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer ImmunotherapyMolecular Cancer TherapeuticsApril 2, 2026Evelyn De Tavernier, Peter S. Kim, Eduardo M. Bruch, Virna F. Cortez-Retamozo, Lien Timmerman, Alyssa L. Flynn, Wouter Van Overbeke, Fabrice Tirode, Valeria Cintra Barbosa-Lorenzi, Peter Piepenhagen, et al.stained using the following antibodies, according to suppliers’ instructions: anti-CD4 (BioLegend, cat. #344648, RRID: AB_2734350), anti-CD8 (BD Biosciences, cat. #563795, RRID: AB_2722501), anti-CD25 (BioLegend,

(2) TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer ImmunotherapyMol Cancer TherJanuary 8, 2026Evelyn De Tavernier, Peter S. Kim, Eduardo M. Bruch, Virna F. Cortez-Retamozo, Lien Timmerman, Alyssa L. Flynn, Wouter Van Overbeke, Fabrice Tirode, Valeria Cintra Barbosa-Lorenzi, Peter Piepenhagen, et al.stained using the following antibodies, according to suppliers’ instructions: anti-CD4 (BioLegend, cat. #344648, RRID: AB_2734350), anti-CD8 (BD Biosciences, cat. #563795, RRID: AB_2722501), anti-CD25 (BioLegend,

(3) Restoration of LAT activity improves CAR T cell sensitivity and persistence in response to antigen-low acute lymphoblastic leukemiaCancer CellMarch 10, 2025Catherine Pham-Danis, Amanda J. Novak, Etienne Danis, Samantha M. McClellan, Lillie Leach, Michael C. Yarnell, Christopher C. Ebmeier, Sarah K. Tasian, M. Eric Kohler(Clone SK7),eBioscience,Cat# 48-0036-42; RRID:AB_1121767 Human CD4-BV711 (Clone SK3),Biolegend,Cat# 344648; RRID:AB_2734350 Human CD4-PerCPCy5.5 (Clone SK3),eBioscience,Cat# 344607; RRID:AB_1953236 Human CD4-APC

(4) Central control of dynamic gene circuits governs T cell rest and activationNatureDecember 11, 2024Maya M. Arce, Jennifer M. Umhoefer, Nadia Arang, Sivakanthan Kasinathan, Jacob W. Freimer, Zachary Steinhart, Haolin Shen, Minh T. N. Pham, Mineto Ota, Anika Wadhera, et al.BioLegend), Ghost Dye Red 780 diluted 1:1,000 (13-0865-T500, Tonbo) and BV711 anti-human CD4 diluted 1:50 (344648, BioLegend) for 20 min at 4 °C and then washed once with EasySep buffer. After fixing and permeabilizing

(5) Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB ReinfectionVaccines (Basel)April 26, 2024Xun Wang, Meng Zhang, Kaifeng Wei, Chen Li, Jinghui Yang, Shujun Jiang, Chaoyue Zhao, Xiaoyu Zhao, Rui Qiao, Yuchen Cui, et al.then stained for 30 min at 4 °C using the following antibodies: Brilliant Violet 711™ anti-human CD4 (344648, BioLegend; 1 μL/well), APC anti-human CD3 (300412, BioLegend; 1 μL/well), and PE/Dazzle™ 594 anti-human CD8

(6) Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody DeficiencyJournal of clinical immunologyAugust 1, 2022Shin JJ, Par-Young J, Unlu S, McNamara A, Park HJ, Shin MS, Gee RJ, Doyle H, Afinogenova Y, Zidan E, et al.BD Biosciences, Clone SK7, Cat#564001, 1:150), BV 711 anti-hCD4 (BioLegend, San Diego, CA, USA, Clone SK3, Cat #344648, 1:150), BV510 anti-hCD8 (BioLegend, Clone SK1, Cat#344732, 1:150), PE-Cy5 anti-hCD45RA (BD Pharmingen,

(7) Noninvasive Imaging of CD4+ T Cells in Humanized MiceMolecular cancer therapeuticsApril 1, 2022Nagle VL, Hertz CAJ, Henry KE, Graham MS, Campos C, Pillarsetty N, Schietinger A, Mellinghoff IK, Lewis JS.using methods previously described (25). Splenocytes were stained with BV711-CD4 (Biolegend, SK3, CAT# 344648, RRID: AB_2734350), BUV395-CD3 (BD Biosciences, UCHT1, CAT# 563548, RRID: AB_2744387), and 7-AAD viability

(8) Rapid Serial Immunoprofiling of the Tumor Immune Microenvironment by Fine Needle SamplingClinical cancer research : an official journal of the American Association for Cancer ResearchSeptember 1, 2021Oh J, Carlson JCT, Landeros C, Lee H, Ferguson S, Faquin WC, Clark JR, Pittet MJ, Pai SI, Weissleder R.antibodies against CD3 (clone SK7, Biolegend Cat# 344805, RRID:AB_10559750), CD4 (clone SK3, Biolegend Cat# 344647, RRID:AB_2734349), CD45 (clone 2D1, Biolegend Cat# 368515, RRID:AB_2566375), CD8 (clone SK1, Biolegend

(9) Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed TissuesJournal of virologyOctober 14, 2020Port JR, Wozniak DM, Oestereich L, Pallasch E, Becker-Ziaja B, Müller J, Rottstegge M, Olal C, Gómez-Medina S, Oyakhliome J, et al.

Be the First to Write a Review!

Brilliant Violet 711™ anti-human CD4 from BioLegend

Description

BioLegend

Citations (9)

Reviews

Brilliant Violet 711™ anti-human CD4 from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map